Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)
Close on Nov 17, 2026Market cap $194.59MP/E –Yield –
Precision BioSciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Precision BioSciences's profit margin for the twelve months ending Jun 30, 2026 was -117.0%. For fiscal 2025 it was -133.4%, against 10.4% the year before. The highest annual figure on record is 10.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -133.4% | −143.9 |
| FY2024 | Dec 31, 2024 | 10.4% | +136.3 |
| FY2023 | Dec 31, 2023 | -125.8% | +319.0 |
| FY2022 | Dec 31, 2022 | -444.8% | −418.3 |
| FY2021 | Dec 31, 2021 | -26.5% | +422.4 |
| FY2020 | Dec 31, 2020 | -448.9% | −31.2 |
| FY2019 | Dec 31, 2019 | -417.6% | +5.4 |
| FY2018 | Dec 31, 2018 | -423.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -170.2% | +70743.6 |
| Q4 FY2025 | Dec 31, 2025 | 58.9% | +2840.2 |
| Q3 FY2025 | Sep 30, 2025 | -167476.9% | −164625.4 |
| Q2 FY2025 | Jun 30, 2025 | -130666.7% | −130732.3 |
| Q1 FY2025 | Mar 31, 2025 | -70913.8% | −70962.6 |
| Q4 FY2024 | Dec 31, 2024 | -2781.3% | −2549.9 |
| Q3 FY2024 | Sep 30, 2024 | -2851.6% | −2790.0 |
| Q2 FY2024 | Jun 30, 2024 | 65.6% | +125.7 |
| Q1 FY2024 | Mar 31, 2024 | 48.8% | +334.3 |
| Q4 FY2023 | Dec 31, 2023 | -231.4% | +37.4 |
| Q3 FY2023 | Sep 30, 2023 | -61.6% | +263.6 |
| Q2 FY2023 | Jun 30, 2023 | -60.1% | +752.3 |
| Q1 FY2023 | Mar 31, 2023 | -285.4% | +563.8 |
| Q4 FY2022 | Dec 31, 2022 | -268.8% | +82.8 |
| Q3 FY2022 | Sep 30, 2022 | -325.2% | −278.3 |
| Q2 FY2022 | Jun 30, 2022 | -812.4% | −843.9 |
| Q1 FY2022 | Mar 31, 2022 | -849.2% | −734.9 |
| Q4 FY2021 | Dec 31, 2021 | -351.6% | −86.5 |
| Q3 FY2021 | Sep 30, 2021 | -46.9% | +306.4 |
| Q2 FY2021 | Jun 30, 2021 | 31.5% | +3065.0 |
| Q1 FY2021 | Mar 31, 2021 | -114.3% | +269.2 |
| Q4 FY2020 | Dec 31, 2020 | -265.1% | +55.6 |
| Q3 FY2020 | Sep 30, 2020 | -353.3% | +73.0 |
| Q2 FY2020 | Jun 30, 2020 | -3033.5% | −2672.8 |
| Q1 FY2020 | Mar 31, 2020 | -383.5% | +198.4 |
| Q4 FY2019 | Dec 31, 2019 | -320.7% | −8.1 |
| Q3 FY2019 | Sep 30, 2019 | -426.4% | −42.4 |
| Q2 FY2019 | Jun 30, 2019 | -360.7% | +270.4 |
| Q1 FY2019 | Mar 31, 2019 | -581.9% | +7.9 |
| Q4 FY2018 | Dec 31, 2018 | -312.6% | – |
| Q3 FY2018 | Sep 30, 2018 | -383.9% | – |
| Q2 FY2018 | Jun 30, 2018 | -631.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -589.8% | – |
See a number that looks wrong?